Suppr超能文献

甲状腺与肝脏之间的代谢和功能相互作用

Metabolic and Functional Cross Talk Between the Thyroid and Liver.

作者信息

Chng Chiaw-Ling, Goh George Boon Bee, Yen Paul Michael

机构信息

Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.

Department of Gastroenterology & Hepatology, Singapore General Hospital, Singapore, Singapore.

出版信息

Thyroid. 2025 May 26. doi: 10.1089/thy.2025.0178.

Abstract

The liver and thyroid have complicated effects on each other's functions and metabolic homeostasis in the body. Both hypo- and hyperthyroidism influence hepatic carbohydrate and fat metabolism to regulate circulating glucose, cholesterol, and triglyceride levels. Hypothyroidism and "intrahepatic" hypothyroidism also contribute to the development of hypercholesterolemia and metabolic dysfunction-associated steatotic liver disease (MASLD). Likewise, hepatic dysfunction can modulate thyroid function by reducing thyroid hormone (TH) concentrations and their effects on peripheral tissues. In this review, we examine the impact of thyroid disorders and their treatment on hepatic physiology, metabolism, and pathology, as well as the influence of liver disease on thyroid function. We also describe the clinical and experimental evidence for THs playing significant roles in metabolic conditions such as metabolic syndrome, hyperlipidemia, and MASLD. Additionally, we summarize the current literature on the use of thyromimetics for the treatment of metabolic diseases. Recognizing the effects of the thyroid and THs on hepatic metabolism and fuel utilization, and the liver's role in modulating systemic TH action, is important for optimal clinical management of patients with thyroid and/or liver diseases. New emerging concepts on TH actions in the liver and the efficacy of thyromimetics for the treatment of MASLD have reshaped our understanding of the thyroid-liver relationship and the roles of THs in the pathogenesis and treatment of metabolic diseases.

摘要

肝脏和甲状腺对彼此的功能以及机体代谢稳态有着复杂的影响。甲状腺功能减退和亢进都会影响肝脏的碳水化合物和脂肪代谢,从而调节循环中的葡萄糖、胆固醇和甘油三酯水平。甲状腺功能减退以及“肝内”甲状腺功能减退也会导致高胆固醇血症和代谢功能障碍相关脂肪性肝病(MASLD)的发生。同样,肝功能障碍可通过降低甲状腺激素(TH)浓度及其对外周组织的作用来调节甲状腺功能。在本综述中,我们探讨了甲状腺疾病及其治疗对肝脏生理、代谢和病理的影响,以及肝脏疾病对甲状腺功能的影响。我们还描述了甲状腺激素在代谢综合征、高脂血症和MASLD等代谢性疾病中发挥重要作用的临床和实验证据。此外,我们总结了目前关于使用甲状腺模拟物治疗代谢性疾病的文献。认识到甲状腺和甲状腺激素对肝脏代谢及燃料利用的影响,以及肝脏在调节全身甲状腺激素作用中的作用,对于甲状腺和/或肝脏疾病患者的最佳临床管理至关重要。关于甲状腺激素在肝脏中的作用以及甲状腺模拟物治疗MASLD疗效的新出现概念,重塑了我们对甲状腺与肝脏关系以及甲状腺激素在代谢性疾病发病机制和治疗中作用的理解。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验